As reported previously, phytoestrogen calycosin and ERβ agonist liquiritigenin could up-regulate ERβ expression and inhibit the activation of mTOR pathway in breast cancer cells and glioma cells, respectively [8, 9]. This evidence concerns the gene ESR2 and breast cancer.